Main news

Preeclampsia Linked to Increased Risk for Heart Disease, Stroke in Offspring Preeclampsia is a major cause of maternal and perinatal morbidity and mortality, affecting as many as 5% of pregnancies worldwide. New evidence suggests that the complication doesn't end with delivery.

Four-Drug Combo Gets BP Down in One Step: QUARTET-USA Use of a combination antihypertensive product containing quarter doses of four different drugs could be an effective strategy to get patients to target blood pressures in one step, a new study suggests.

AI eye checks can predict heart disease risk in less than minute, finds study Breakthrough opens door to a highly effective, non-invasive test that does not need to be done in a clinic. An artificial intelligence tool that scans eyes can accurately predict a person’s risk of heart disease in less than a minute, researchers say.

ACC Issues Guidance on ED Evaluation of Acute Chest Pain The American College of Cardiology (ACC) has released an Expert Consensus Decision Pathway (ECDP) on the evaluation and disposition of acute chest pain in the emergency department (ED). Chest pain accounts for more than 7 million ED visits annually. A major challenge is to quickly identify the small number of patients with acute coronary syndrome (ACS) among the large number of patients who have noncardiac conditions.

Adding Cardiac Shockwave to CABG Boosts LVEF, Function, QoL In patients undergoing coronary artery bypass graft (CABG) surgery for ischemic cardiomyopathy, adjunctive cardiac shockwave therapy (SWT) improved left ventricular ejection fraction (LVEF) in the single-center CAST-HF study.

Artificial intelligence for the echocardiographic assessment of valvular heart disease Developments in artificial intelligence (AI) have led to an explosion of studies exploring its application to cardiovascular medicine. Due to the need for training and expertise, one area where AI could be impactful would be in the diagnosis and management of valvular heart disease. This is because AI can be applied to the multitude of data generated from clinical assessments, imaging and biochemical testing during the care of the patient.

Smartphone detection of atrial fibrillation using photoplethysmography: a systematic review and meta-analysis The development of novel screening devices has the potential to increase screening coverage and improve clinical detection of AF. Smartphone applications can allow self-detection of arrhythmias, allowing for patient self-care and involvement.6 Photoplethysmography (PPG) technology found in smartphone cameras can be used for AF screening by patients in the community. The technique uses the light-emitting diode in cameras to measure pulsatile changes in light intensity that are reflected from a finger (or face). Several smartphone PPG applications are currently available, but their clinical value for AF detection is unclear.

A Week of Anticoagulation Halves Post-PCI Radial Occlusion Rate BOSTON — Following transradial access for angiography or a percutaneous coronary intervention (PCI), a low dose of the factor Xa inhibitor rivaroxaban for 7 days reduces the risk of an access-site occlusion by 50%, according to results of the randomized RIVARAD trial.

Expert Consensus Guides Use of Cardiac CT in Patients With Cancer The Society of Cardiovascular Computed Tomography (SCCT) has issued an expert consensus statement to guide use of cardiac computed tomography (CCT) in the care of cardio-oncology patients.

Frailty Poses No Limit to HFpEF Meds BARCELONA — Increased frailty of patients with heart failure with preserved ejection fraction (HFpEF) should have no bearing on whether those patients receive sacubitril/valsartan (Entresto), according to results of a post hoc analysis of data from a pivotal trial.

New ACC, AHA, SCAI Interventional Cardiology Training Guidance
New ACC, AHA, SCAI Interventional Cardiology Training Guidance The American College of Cardiology (ACC), the American Heart Association (AHA), and the Society for Cardiovascular Angiography and Interventions (SCAI) have jointly issued new guidance outlining competency-based advanced training requirements for interventional cardiology trainees.

Guidance for PCI Without Onsite Surgical Backup Updated
Guidance for PCI Without Onsite Surgical Backup Updated The Society for Cardiovascular Angiography and Interventions has issued an updated expert consensus statement to provide clearer guidance on what percutaneous coronary angioplasty cases can be done in outpatient settings such as ambulatory surgery centers (ASCs) and office-based laboratories and which are best left to more traditional settings, such as hospitals with full cardiac support.

Editorial Activity

cardiology book

Prof. Aronow's career path
Prof. Aronow's career path Dear colleagues! The Cardioprogress Foundation presents the excerpts from the memoirs of the International Journal of Heart and Vascular Diseases editorial board member Wilbert S. Aronov, a cardiologist, professor of medicine, member of the FACC, FAHA, FACP, FCCP, FASPC, AGSF, FGSA. Dr. Wilbert Solomon Aronow was born in New York City on October 30, 1931. His parents were Russian Jewish immigrants. His grandparents were rabbis in Russia. Doctor Aronov dedicated his professional career to medicine.

World Heart Day 2022 in Iloilo
World Heart Day 2022 in Iloilo Iloilo province made history for hosting this year’s World Heart Day. It was chosen by the World Health Organization (WHO) as pilot area for the celebration. As highlight of the event, the whole façade of the Iloilo provincial capitol was illuminated on Thursday night, Sept. 29. The ceremonial event was led by Gov. Arthur Defensor Jr.; Department of Health (DOH) undersecretaries Dr. Kenneth Ronquillo and Atty. Charade Grande; DOH Western Visayas regional director, Dr. Adriano Zubaan; and representatives from WHO, Resolve to Save Lives, and World Heart Federation.

Climate change and health inequity a deadly mix for the most vulnerable: World Heart Federation
Climate change and health inequity a deadly mix for the most vulnerable: World Heart Federation Geneva, 29 September 2022 - On World Heart Day, the World Heart Federation (WHF) is calling for urgent action on climate change and health inequity, with millions more lives now at risk from cardiovascular disease, which is still the world’s biggest killer.

New ESC Guidelines for Cutting CV Risk in Noncardiac Surgery
New ESC Guidelines for Cutting CV Risk in Noncardiac Surgery The European Society of Cardiology (ESC) guidelines on cardiovascular assessment and management of patients undergoing noncardiac surgery have seen extensive revision since the 2014 version. They still have the same aim — to prevent surgery-related bleeding complications, perioperative myocardial infarction/injury (PMI), stent thrombosis, acute heart failure, arrhythmias, pulmonary embolism, ischemic stroke, and cardiovascular (CV) death.

U.S. declares monkeypox public health emergency
U.S. declares monkeypox public health emergency Following growing pressure to ramp up response efforts against monkeypox, the U.S. declared a public health emergency. There are around 6,600 infections nationwide, reaching all but two states. The White House plans to roll out several million doses of monkeypox vaccines and are targeting at-risk communities.

FDA Okays IN.PACT 018 Drug-Coated Balloon for PAD
FDA Okays IN.PACT 018 Drug-Coated Balloon for PAD The US Food and Drug Administration has approved the IN.PACT 018 drug-coated balloon (DCB) for the treatment of peripheral arterial disease, Medtronic announced today.

World Heart Summit 2022
World Heart Summit 2022 THE SUMMIT WILL CONVENE WORLD LEADERS IN CARDIOVASCULAR HEALTH IN THE HEART OF GLOBAL HEALTH DIPLOMACY, JUST AHEAD OF THE 75TH WORLD HEALTH ASSEMBLY. Now in its 7th edition, the World Heart Summit will take place on 21-22 May 2022, just two days ahead of the World Health Assembly, under the timely and universal theme of Cardiovascular Health for Everyone.